123 related articles for article (PubMed ID: 11005553)
1. Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients.
McCready DR; Chapman JA; Hanna WM; Kahn HJ; Yap K; Fish EB; Lickley HL
Ann Surg Oncol; 2000 Sep; 7(8):562-7. PubMed ID: 11005553
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with local breast cancer recurrence after lumpectomy alone.
McCready DR; Hanna W; Kahn H; Chapman JA; Wall J; Fish EB; Lickley HL
Ann Surg Oncol; 1996 Jul; 3(4):358-66. PubMed ID: 8790848
[TBL] [Abstract][Full Text] [Related]
3. Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone.
Chapman JW; Hanna W; Kahn HJ; Lickley HL; Wall J; Fish EB; McCready DR
Surg Oncol; 1996; 5(5-6):265-71. PubMed ID: 9129140
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
Allred DC; Anderson SJ; Paik S; Wickerham DL; Nagtegaal ID; Swain SM; Mamounas EP; Julian TB; Geyer CE; Costantino JP; Land SR; Wolmark N
J Clin Oncol; 2012 Apr; 30(12):1268-73. PubMed ID: 22393101
[TBL] [Abstract][Full Text] [Related]
5. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
7. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Characteristics of Breast Cancer that Predict for Local Recurrence After Lumpectomy Alone.
Hanna WM; Kahn HJ; Chapman JA; Fish EB; Lickley HL; McCready DR
Breast J; 1999 Mar; 5(2):105-111. PubMed ID: 11348268
[TBL] [Abstract][Full Text] [Related]
9. Management of positive margins after initial lumpectomy in elderly women with breast cancer.
Angarita FA; Acuna SA; McCready DR; Escallon J
Eur J Surg Oncol; 2018 Jul; 44(7):1048-1053. PubMed ID: 29525464
[TBL] [Abstract][Full Text] [Related]
10. Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin.
Ishitobi M; Matsushita A; Nakayama T; Motomura K; Koyama H; Tamaki Y
J Surg Oncol; 2014 Sep; 110(3):265-9. PubMed ID: 24863697
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
[TBL] [Abstract][Full Text] [Related]
12. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
Lagios MD; Silverstein MJ
Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
15. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
Fish EB; Chapman JA; Miller NA; Link MA; Fishell E; Wright B; McCready DR; Hiraki GY; Ross TM; Hanna WM; Lickley HL
Ann Surg Oncol; 1998 Dec; 5(8):724-32. PubMed ID: 9869520
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
17. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
18. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
[TBL] [Abstract][Full Text] [Related]
19. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
Van Zee KJ; Liberman L; Samli B; Tran KN; McCormick B; Petrek JA; Rosen PP; Borgen PI
Cancer; 1999 Nov; 86(9):1757-67. PubMed ID: 10547549
[TBL] [Abstract][Full Text] [Related]
20. Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ?
Chaudhary LN; Jawa Z; Hanif A; Szabo A; Kamaraju S; Cheng YC; Chitambar CR
WMJ; 2018 Jun; 117(2):62-67. PubMed ID: 30048574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]